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Background and purpose: Huntington's disease (HD) is a neurodegenerative, progressive
disorder of the central nervous system which causes signiﬁcant gait and balance distur-
bances. This is a pilot study which aims to determine the effects of a physiotherapy
programme with use of Proprioceptive Neuromuscular Facilitation (PNF) on gait and balance
in HD patients.
Material and methods: 30 HD patients aged 21–60 with genetically conﬁrmed diagnosis
participated in the study. Participants followed a 3-week-long PNF-based physiotherapy
programme. Gait and balance were evaluated twice in each participant: ﬁrst at baseline and
then after the course of physiotherapy. The following methods were used for gait distur-
bances: Tinetti Gait Assessment Tool, Up and Go Test, Timed Walking Tests for 10 m and
20 m (TWT10m, TWT20m). Balance was assessed with use of Berg Balance Scale, Pastor Test
and Functional Reach Test.
Results: There was a signiﬁcant improvement in all measures of balance and gait.
Conclusion: PNF-based physiotherapy is effective and safe in HD patients.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Huntington's disease (HD) is a neurodegenerative, progressive
disorder of the central nervous system inherited in an* Corresponding author at: University School of Physical Education in C
E-mail address: mirek.ela@wp.pl (E. Mirek).
http://dx.doi.org/10.1016/j.pjnns.2015.09.002
0028-3843/# 2015 Polish Neurological Society. Published by Elsevier Sautosomal dominant trait. HD is clinically manifested by
cognitive impairment, behavioural signs and a variety of
movement disorders including chorea, dystonia, ataxia or
parkinsonism [1]. All of these movement disorders cause gait
disturbances and increase the risk of falls [2]. The typicalracow, Al. Jana Pawła II 78, Kraków, Poland. Tel.: +48 695 327 424.
p. z o.o. All rights reserved.
Table 1 – Characteristics of the study group.
Patients Mean Standard
deviation
Range
Age (years) 43.4 13.8 20–60
Number of CAG repetitions 46.6 6.0 40–62
Disease duration (years) 7.0 5.8 2–10
UHDRS cognitive 123.9 43.31 10–186
UHDRS motor 40.8 20.0 10–78
UHDRS functional assessment 17.6 4.6 7–25
UHDRS independence scale 76.67 13.2 50–100
TFC 7.7 3.1 3–13
UHDRS – uniﬁed Huntington's disease rating scale; TFC – total
functional capacity.
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of gait velocity and frequency, extended gait cycle, prolonged
double support phase, shortening of the step length, and large
variability in the length and height of steps [3–6]. The
mechanism of gait disturbances in HD is still unknown.
Involuntary movements seem to play minor role and their
treatment does not improve gait [6]. Another symptom of HD is
balance disturbances. Recent study shows that HD patients
produce more sway than control subjects during standing.
Furthermore, they have slower reaction and more falls while
unexpected or sudden rotation of the support surface [7]. Gait
and balance dysfunction occur in an early stage of the disease
[8]. So far there have been several papers on gait and balance
disorder in Huntington disease, most of them included small
numbers of participants and showed positive results of
rehabilitation and physical therapy [9–11] and none of them
used a special physiotherapeutic technique. There is no
established pharmacotherapy of gait or balance disturbances
in HD therefore physiotherapy appears encouraging thera-
peutic option [12,13]. Physiotherapy techniques constitute the
primary treatment approach in the management of gait and
balance disturbances irrespectively of the cause. Propriocep-
tive Neuromuscular Facilitation (PNF) is one of widely used
methods of physiotherapy. It is a complex technique of neuro-
muscular re-education [14] which is based on the maximal
stimulation of proprioceptive and external (touch, verbal,
visual) receptors aiming at activation of impaired structures
of the nervous system. PNF was previously found effective in
the treatment of gait and balance disturbances in Parkinson's
disease (PD) [15,16]. This study aims to determine the effects
of the PNF physiotherapy programme on gait and balance of
patients with Huntington's disease.
2. Material and methods
The study was conducted between October 2009 and May 2010
according to the Declaration of Helsinki and was approved by
the Local Ethical Committee. The inclusion criteria were as
follows: mutation in the HTT gene in genetic testing, HD motor
manifestation (chorea, dystonia, and/or gait disturbances) at
baseline neurological examination, stable pharmacotherapy
for at least one month prior to inclusion, the patient's
informed consent to participate in the study. The exclusion
criteria were: severe disability (stage 5 of the Shoulson and
Fahn scale [17]), signiﬁcant cognitive dysfunction or psychiat-
ric symptoms (e.g. aggression, psychosis, depression) that
prevented effective cooperation between the patient and
physiotherapist, any orthopaedic condition (e.g. fractures,
sprains) impeding movement. Participation in the study was
offered to 34 consecutive HD patients admitted to the
Department of Neurology, Outpatients Clinic. Two patients
refused to take part in the study. The remaining 32 patients
were included in the study, followed baseline examination and
entered the physiotherapy programme. Two patients were
excluded during the course of physiotherapy because of an
outburst of impulsive behaviour. The characteristics of the
study group are shown in Table 1. The intervention was a
3-week-long intensive physiotherapy programme. Physiother-
apy was provided ﬁve days a week (15 sessions). During eachsession the treating physiotherapist applied all the main
techniques and principles of facilitation (e.g. slow approxima-
tion, timing for emphasis, bilateral reciprocal patterns)
according to the PNF concept and used mainly the closed
kinematic chains. Each session was 90 min long and consisted
of three parts:
- introductory part (10 min) which included: warm-up, edu-
cation of a correct body awareness and respiratory pattern,
- main part (70 min) which included: improvement of balance
reactions, mat activities (rolling/prone on elbows/bridging/
side sitting/quadruped/kneeling/half-kneeling/standing),
exercises in a sitting position (rocking/scooting), gait training
(weight shifting/one leg standing/walking forward, back-
ward, sideways/braiding),
- end part (10 min) which included relaxation techniques.
Pharmacotherapy was not changed during the study
period. Gait and balance were evaluated twice in each
participant: ﬁrst at baseline and then immediately after the
completion of the physiotherapy programme. The following
methods were used for gait assessment: Timed Walking Test
for 10 m (TWT10m) and Timed Walking Test for 20 m
(TWT20m) [18,19], Up and Go Test (TUG) [20], Tinetti Gait
Assessment Tool [21]. Balance was assessed with use of the
Functional Reach Test (FRT) [22], Berg Balance Scale (BBS) [7]
and Pastor Test [23]. Statistical analysis was done in the group
of 30 patients who completed the course of physiotherapy
and ﬁnal examination. The analysis was performed using
STATISTICA® 9 Statsoft. The non-parametric Wilcoxon test
(matched pairs) was used. For correlation analysis Spearman's
rank correlation coefﬁcient was used.
3. Results
The improvement of static and dynamic balance was seen in
a clinical scale (BBS) as well as in anticipatory balance tests
(FRT, Pastor Test). The improvement of gait was signiﬁcant
in all tests. Gait and balance improvement seem to be higher
in patients with more advanced gait disturbances. Unwanted
effects of PNF were not identiﬁed. The two patients who were
excluded from the study because of behavioural disturbances
had had episodes of impulsive behaviours in the past,
therefore we do not regard behavioural outbursts as an
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measures before and after the course of physiotherapy as well
as the mean difference are presented in Table 2.
4. Discussion
Previous studies show that rehabilitation (physiotherapy,
occupational therapy, speech therapy) appears effective in
the improvement of gait, balance, mobility and physical
capability in HD and enhances patients independence
[10,24,25]. The efﬁcacy of physiotherapy alone was evaluated
in a single study by Bohlen in 12 HD patients. The patients
were provided physiotherapy twice-weekly over 6 weeks.
Signiﬁcant improvements after physiotherapy were seen in
TUG and BBS [11]. Improvement of motor disturbances after
various antidopaminergic drugs is known in HD. However,
there is sparse data in the literature on pharmacotherapy of
gait and balance disturbances [26]. As compared to the data
on the efﬁcacy of PNF in PD patients, the improvement in gait
and balance in our HD sample is rather small [15]. The possible
explanation for the remarkably lower efﬁcacy of PNF may be
the cognitive impairment and behavioural disturbances of
the HD patients. Although patients with severe dementia were
excluded, the executive dysfunction of the participants might
have affected therapy. Nevertheless physiotherapy of patients
with cognitive impairment is possible and may be effective
as shown in a study in Alzheimer's disease [27]. Another
potentially confounding factor affecting treatment is beha-
vioural disturbances. Apathy deﬁned as lack of motivation
seems to be the most common and troublesome behavioural
symptom in HD [28]. Neither cognitive dysfunction nor
behavioural disturbances were analysed as confounders of
PNF efﬁcacy in the present study.
The assessment of the efﬁcacy of any therapeutic inter-
vention is an extremely important part of its developmentTable 2 – Descriptive statistics for measurements before and a
Test Me Q1 Q3 Mean (r
Berg Balance Scale (score) BA 50 43 53 46.9 (19.0
FA 52.5 50.0 56.0 52.5 (38.0
Pastor Test (score) BA 2.5 2.0 3.0 2.5 (1–4
FA 1.0 1.0 2.0 1.5 (1–4
Functional Reach Test (cm) BA 25.0 21.0 32.0 25.6 (0.0–
FA 32.0 28.0 42.0 34.1 (14.0
Tinetti Gait Assessment
Tool (score)
BA 8.0 5.0 10.0 7.8 (2–1
FA 11.0 10.0 13.0 11.1 (8–1
Up and Go Test (s) BA 9.1 7.5 11.3 9.5 (6.0–
FA 7.0 6.4 8.6 7.7 (5.5–
Timed Walking Test 10 m (s) BA 7.9 7.2 9.2 8.3 (6.1–
FA 7.6 6.5 8.3 7.6 (5.3–
Timed Walking Test 20 m (s) BA 15.9 14.7 20.2 17.2 (12.5
FA 14.2 13.0 17.0 14.8 (11.3
Me – median; Q1 – ﬁrst quartile; Q3 – third quartile; BA – baseline assessand implementation. We have identiﬁed three groups of
methods that may be applied to formal efﬁcacy assessment:
global functional scales or speciﬁc scales for gait, posture or
neurologic signs assessment (e.g. TFC, UHDRS, BBS), functional
tests (e.g. FRT, TWT10m) or instrumental methods, e.g. 3-D
gait analysis. So far, none of the mentioned methods has been
regarded as a gold standard of gait or balance assessment. The
methods of gait and balance assessment applied in this study
provide reliable and multidimensional information on gait
and balance disturbances [1] and have been previously used
in the assessment of a therapeutic interventions on gait or
balance [29,30].
Some limitations of the present study should be raised.
First, the sample was small, thus it was not possible to
stratify the results to disease severity, cognitive impairment,
behavioural disturbances or drug allocation. Second, the
sample was quite inhomogeneous in terms of the severity
of symptoms and baseline measures of gait and balance.
Another weakness of the study was lack of a delayed
assessment of gait and balance following the ﬁnal assess-
ment. However, taking into account the study by Zinzi et al.,
who showed that there is a continuous effect of rehabilita-
tion in HD after two years [10], we believe that PNF may also
provide an unfading effect.
It is a matter of debate whether use of a protocol with a
no-physiotherapy control group provides any additional
information. We assume that the prerequisite of stable
pharmacological treatment throughout the study and one
month prior to inclusion excludes confounding effects of
medication on the results of the study.
The efﬁcacy of PNF should now be estimated in a group
of early stage HD patients, and long-term effects should
also be evaluated. Further research is also needed to predict
the best responders to this method and compare PNF
with other physiotherapeutic methods and pharmacologic
therapy.fter PNF therapy.
ange) Standard
deviation
Mean
difference
(range)
Standard
deviation of
difference
p-Value
–30.0) 8.6
–56.0) 5.3 5.6 (20–0) 5.7 0.000008
) 1.0
) 0.8 1.0 (0.0–3) 0.8 0.000040
46.0) 10.9
–52.0) 9.5 9.4 (27.0–0.0) 7.3 0.000006
3) 2.9
3) 1.8 3.3 (9–0) 2.1 0.000003
14.4) 2.4
11.9) 1.7 1.8 (2.1–5.0) 1.8 0.000021
13.9) 1.6
11.5) 1.5 0.7 (1.8–4.3) 1.2 0.002415
–26.6) 3.6
–21.3) 2.6 2.3 (3.2–9.7) 2.6 0.000024
ment, FA – ﬁnal assessment.
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The present study shows that gait and balance in HD patients
improved after PNF therapy. PNF is based on the concept of
stimulation of the brain in order to employ the compensatory
mechanisms and neuronal plasticity to restore the lost
function. The efﬁcacy of PNF in HD demonstrates that the
brain of a HD person which is globally burdened, may still be
successfully stimulated. We suggest that physiotherapy based
on the PNF concept should be used in HD as a complementary
method to pharmacotherapy because it is safe and efﬁcient.
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